US Stock MarketDetailed Quotes

URGN UroGen Pharma Ltd

Watchlist

12.900
+0.150+1.18%

Close Sep 27 16:00 ET

12.900
0.0000.00%

Post 16:02 ET

543.27MMarket Cap-4174P/E (TTM)

UroGen Pharma Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-17.14%-23.75M

-22.97%-31.74M

12.77%-76.38M

40.25%-13M

1.78%-17.3M

16.22%-20.27M

-7.55%-25.81M

-3.14%-87.56M

-8.38%-21.75M

4.68%-17.61M

Net income from continuing operations

-38.39%-33.4M

-6.86%-32.29M

6.87%-102.24M

9.88%-26.02M

15.30%-21.88M

9.57%-24.14M

-6.41%-30.21M

0.94%-109.78M

-1.47%-28.87M

14.50%-25.83M

Operating gains losses

7.43%3.34M

-9.54%2.6M

-17.87%11.5M

-6.63%2.79M

2.71%2.73M

-23.61%3.11M

-33.01%2.87M

-5.66%14.01M

-52.31%2.99M

-57.46%2.66M

Depreciation and amortization

-38.98%263K

-19.31%351K

-6.16%1.71M

-5.78%424K

-4.60%415K

-9.45%431K

-4.61%435K

2.48%1.82M

-0.22%450K

-3.76%435K

Other non cash items

-37.18%223K

-337.87%-961K

-61.36%1.01M

-96.46%33K

-78.32%222K

-8.03%355K

43.26%404K

--2.62M

--932K

--1.02M

Change In working capital

231.98%2.57M

-223.99%-4.01M

152.90%3.34M

866.07%7.57M

-154.89%-1.06M

63.86%-1.95M

65.90%-1.24M

55.85%-6.31M

120.50%784K

247.96%1.92M

-Change in receivables

-8.13%-3.26M

509.00%1.29M

-177.51%-2.74M

20.73%-2.6M

22.71%2.66M

-43.70%-3.01M

-90.49%211K

78.87%-987K

16.75%-3.28M

25.35%2.17M

-Change in inventory

-141.72%-199K

-37.72%-1.57M

-272.38%-1.35M

-337.10%-671K

91.52%-14K

185.79%477K

-1,600.00%-1.14M

87.38%-362K

127.64%283K

57.36%-165K

-Change in prepaid assets

-197.57%-1.72M

79.90%-210K

122.61%820K

1,202.87%5.76M

-2,170.55%-3.32M

50.17%-577K

41.94%-1.05M

11.80%-3.63M

61.67%-522K

81.86%-146K

-Change in payables and accrued expense

593.95%7.46M

-398.72%-4.21M

322.14%6.71M

9.83%5.12M

-198.23%-889K

26,975.00%1.08M

135.49%1.41M

361.51%1.59M

223.99%4.66M

117.55%905K

-Change in other current assets

23.55%425K

323.28%940K

155.32%702K

104.46%12K

237.95%767K

225.09%344K

-149.11%-421K

-24.41%-1.27M

-148.64%-269K

-1.65%-556K

-Change in other current liabilities

22.62%-195K

1.98%-247K

50.91%-811K

51.09%-45K

7.09%-262K

80.51%-252K

-1,780.00%-252K

-64.54%-1.65M

-118.22%-92K

83.45%-282K

Cash from discontinued investing activities

Operating cash flow

-17.14%-23.75M

-22.97%-31.74M

12.77%-76.38M

40.25%-13M

1.78%-17.3M

16.22%-20.27M

-7.55%-25.81M

-3.14%-87.56M

-8.38%-21.75M

4.68%-17.61M

Investing cash flow

Cash flow from continuing investing activities

222.53%12M

115.60%13.52M

-189.91%-953K

-149.09%-11.34M

101.13%401K

2,563.58%3.72M

-53.88%6.27M

-73.95%1.06M

153.24%23.11M

-432.95%-35.49M

Net PPE purchase and sale

-460.00%-84K

--0

23.62%-194K

-330.77%-56K

34.64%-100K

76.19%-15K

8.00%-23K

66.22%-254K

93.56%-13K

21.13%-153K

Net investment purchase and sale

223.48%12.08M

114.81%13.52M

-157.76%-759K

-148.82%-11.29M

101.42%501K

4,344.32%3.74M

-53.80%6.29M

-72.74%1.31M

147.89%23.12M

-425.59%-35.34M

Cash from discontinued investing activities

Investing cash flow

222.53%12M

115.60%13.52M

-189.91%-953K

-149.09%-11.34M

101.13%401K

2,563.58%3.72M

-53.88%6.27M

-73.95%1.06M

153.24%23.11M

-432.95%-35.49M

Financing cash flow

Cash flow from continuing financing activities

70,029.37%100.29M

8,045.60%54.66M

20.38%116.93M

-99.84%40K

10,442.87%116.08M

285.71%143K

-99.05%671K

34.31%97.13M

79,375.00%25.37M

755.36%1.1M

Net issuance payments of debt

----

--0

----

--95.78M

--24.99M

--0

Net common stock issuance

--81.51M

--54.66M

--67.36M

--0

--67.36M

--0

----

Proceeds from stock option exercised by employees

13,030.07%18.78M

--0

3,180.81%49.57M

-89.42%40K

4,261.59%48.72M

793.75%143K

--671K

2,377.05%1.51M

--378K

37,133.33%1.12M

Net other financing activities

----

-100.22%-160K

--0

90.64%-16K

Cash from discontinued financing activities

Financing cash flow

70,029.37%100.29M

8,045.60%54.66M

20.38%116.93M

-99.84%40K

10,442.87%116.08M

285.71%143K

-99.05%671K

34.31%97.13M

79,375.00%25.37M

755.36%1.1M

Net cash flow

Beginning cash position

254.08%132.26M

70.44%95.82M

23.33%56.22M

307.22%120.12M

-74.30%20.94M

-64.74%37.35M

23.32%56.22M

-15.72%45.59M

-47.85%29.5M

26.27%81.5M

Current changes in cash

639.49%88.54M

293.15%36.44M

272.37%39.6M

-190.93%-24.3M

290.71%99.18M

32.82%-16.41M

-131.27%-18.87M

225.06%10.64M

343.45%26.72M

-551.35%-52M

End cash Position

954.28%220.8M

254.08%132.26M

70.44%95.82M

307.22%120.12M

-74.30%20.94M

-64.74%37.35M

23.33%56.22M

-47.85%29.5M

Free cash flow

-17.46%-23.83M

-22.86%-31.74M

12.80%-76.57M

40.03%-13.05M

2.06%-17.4M

16.38%-20.29M

-7.53%-25.83M

-2.53%-87.81M

-7.36%-21.77M

4.85%-17.77M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-17.14%-23.75M	-22.97%-31.74M	12.77%-76.38M	40.25%-13M	1.78%-17.3M	16.22%-20.27M	-7.55%-25.81M	-3.14%-87.56M	-8.38%-21.75M	4.68%-17.61M
Net income from continuing operations	-38.39%-33.4M	-6.86%-32.29M	6.87%-102.24M	9.88%-26.02M	15.30%-21.88M	9.57%-24.14M	-6.41%-30.21M	0.94%-109.78M	-1.47%-28.87M	14.50%-25.83M
Operating gains losses	7.43%3.34M	-9.54%2.6M	-17.87%11.5M	-6.63%2.79M	2.71%2.73M	-23.61%3.11M	-33.01%2.87M	-5.66%14.01M	-52.31%2.99M	-57.46%2.66M
Depreciation and amortization	-38.98%263K	-19.31%351K	-6.16%1.71M	-5.78%424K	-4.60%415K	-9.45%431K	-4.61%435K	2.48%1.82M	-0.22%450K	-3.76%435K
Other non cash items	-37.18%223K	-337.87%-961K	-61.36%1.01M	-96.46%33K	-78.32%222K	-8.03%355K	43.26%404K	--2.62M	--932K	--1.02M
Change In working capital	231.98%2.57M	-223.99%-4.01M	152.90%3.34M	866.07%7.57M	-154.89%-1.06M	63.86%-1.95M	65.90%-1.24M	55.85%-6.31M	120.50%784K	247.96%1.92M
-Change in receivables	-8.13%-3.26M	509.00%1.29M	-177.51%-2.74M	20.73%-2.6M	22.71%2.66M	-43.70%-3.01M	-90.49%211K	78.87%-987K	16.75%-3.28M	25.35%2.17M
-Change in inventory	-141.72%-199K	-37.72%-1.57M	-272.38%-1.35M	-337.10%-671K	91.52%-14K	185.79%477K	-1,600.00%-1.14M	87.38%-362K	127.64%283K	57.36%-165K
-Change in prepaid assets	-197.57%-1.72M	79.90%-210K	122.61%820K	1,202.87%5.76M	-2,170.55%-3.32M	50.17%-577K	41.94%-1.05M	11.80%-3.63M	61.67%-522K	81.86%-146K
-Change in payables and accrued expense	593.95%7.46M	-398.72%-4.21M	322.14%6.71M	9.83%5.12M	-198.23%-889K	26,975.00%1.08M	135.49%1.41M	361.51%1.59M	223.99%4.66M	117.55%905K
-Change in other current assets	23.55%425K	323.28%940K	155.32%702K	104.46%12K	237.95%767K	225.09%344K	-149.11%-421K	-24.41%-1.27M	-148.64%-269K	-1.65%-556K
-Change in other current liabilities	22.62%-195K	1.98%-247K	50.91%-811K	51.09%-45K	7.09%-262K	80.51%-252K	-1,780.00%-252K	-64.54%-1.65M	-118.22%-92K	83.45%-282K
Cash from discontinued investing activities
Operating cash flow	-17.14%-23.75M	-22.97%-31.74M	12.77%-76.38M	40.25%-13M	1.78%-17.3M	16.22%-20.27M	-7.55%-25.81M	-3.14%-87.56M	-8.38%-21.75M	4.68%-17.61M
Investing cash flow
Cash flow from continuing investing activities	222.53%12M	115.60%13.52M	-189.91%-953K	-149.09%-11.34M	101.13%401K	2,563.58%3.72M	-53.88%6.27M	-73.95%1.06M	153.24%23.11M	-432.95%-35.49M
Net PPE purchase and sale	-460.00%-84K	--0	23.62%-194K	-330.77%-56K	34.64%-100K	76.19%-15K	8.00%-23K	66.22%-254K	93.56%-13K	21.13%-153K
Net investment purchase and sale	223.48%12.08M	114.81%13.52M	-157.76%-759K	-148.82%-11.29M	101.42%501K	4,344.32%3.74M	-53.80%6.29M	-72.74%1.31M	147.89%23.12M	-425.59%-35.34M
Cash from discontinued investing activities
Investing cash flow	222.53%12M	115.60%13.52M	-189.91%-953K	-149.09%-11.34M	101.13%401K	2,563.58%3.72M	-53.88%6.27M	-73.95%1.06M	153.24%23.11M	-432.95%-35.49M
Financing cash flow
Cash flow from continuing financing activities	70,029.37%100.29M	8,045.60%54.66M	20.38%116.93M	-99.84%40K	10,442.87%116.08M	285.71%143K	-99.05%671K	34.31%97.13M	79,375.00%25.37M	755.36%1.1M
Net issuance payments of debt	----	----	--0	--0	----	----	----	--95.78M	--24.99M	--0
Net common stock issuance	--81.51M	--54.66M	--67.36M	--0	--67.36M	--0	--0	--0	--0	----
Proceeds from stock option exercised by employees	13,030.07%18.78M	--0	3,180.81%49.57M	-89.42%40K	4,261.59%48.72M	793.75%143K	--671K	2,377.05%1.51M	--378K	37,133.33%1.12M
Net other financing activities	----	----	----	----	----	----	----	-100.22%-160K	--0	90.64%-16K
Cash from discontinued financing activities
Financing cash flow	70,029.37%100.29M	8,045.60%54.66M	20.38%116.93M	-99.84%40K	10,442.87%116.08M	285.71%143K	-99.05%671K	34.31%97.13M	79,375.00%25.37M	755.36%1.1M
Net cash flow
Beginning cash position	254.08%132.26M	70.44%95.82M	23.33%56.22M	307.22%120.12M	-74.30%20.94M	-64.74%37.35M	23.32%56.22M	-15.72%45.59M	-47.85%29.5M	26.27%81.5M
Current changes in cash	639.49%88.54M	293.15%36.44M	272.37%39.6M	-190.93%-24.3M	290.71%99.18M	32.82%-16.41M	-131.27%-18.87M	225.06%10.64M	343.45%26.72M	-551.35%-52M
End cash Position	954.28%220.8M	254.08%132.26M	70.44%95.82M	70.44%95.82M	307.22%120.12M	-74.30%20.94M	-64.74%37.35M	23.33%56.22M	23.33%56.22M	-47.85%29.5M
Free cash flow	-17.46%-23.83M	-22.86%-31.74M	12.80%-76.57M	40.03%-13.05M	2.06%-17.4M	16.38%-20.29M	-7.53%-25.83M	-2.53%-87.81M	-7.36%-21.77M	4.85%-17.77M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data